Study Comparing a Pantoprazole Formulation to the Currently Marketed Tablet for GERD and Erosive Esophagitis

Clinical trial NCT00195208 · COMPLETED

Trial details

NCT number: NCT00195208
Sponsor: Wyeth is now a wholly owned subsidiary of Pfizer
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Gastroesophageal Reflux Esophagitis

Start date: 2005-06-01
Primary completion: 2005-11-01
Enrollment: 97

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.